Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falcioni

Showing results (511-520 of 525) with videos related to

Pageof 53
Sort By:
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Plants (Basel, Switzerland)|September 13, 2025
Progressive Water Deficit Impairs Soybean Growth, Alters Metabolic Profiles, and Decreases Photosynthetic EfficiencyRenan Falcioni, Caio Almeida de Oliveira, Nicole Ghinzelli Vedana, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 10, 2018
Gain-of-function mutations in DNMT3A in patients with paragangliomaLaura Remacha, Maria Currás-Freixes, Raúl Torres-Ruiz, et al.
Frontiers in Oncology|July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology|May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Transplantation and Cellular Therapy|November 24, 2021
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and CriticismsMichele Malagola, Nicola Polverelli, Vicky Rubini, et al.
Transplantation Direct|February 27, 2023
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Nicola Polverelli, Massimo Martino, et al.
Pesticide Biochemistry and Physiology|April 25, 2026
Inhibitors of isocitrate lyase for weed suppression: Molecular modeling and biological evaluationPaulo Vinicius Moreira da Costa Menezes, Isabela Ferreira Henrique, Larissa Ayumi Kajihara, et al.
Bone Marrow Transplantation|October 31, 2017
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)L Giaccone, G Mancini, N Mordini, et al.
Pageof 53

Showing results (511-520 of 525) with videos related to

Sort By:
Pageof 53
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Plants (Basel, Switzerland)|September 13, 2025
Progressive Water Deficit Impairs Soybean Growth, Alters Metabolic Profiles, and Decreases Photosynthetic EfficiencyRenan Falcioni, Caio Almeida de Oliveira, Nicole Ghinzelli Vedana, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 10, 2018
Gain-of-function mutations in DNMT3A in patients with paragangliomaLaura Remacha, Maria Currás-Freixes, Raúl Torres-Ruiz, et al.
Frontiers in Oncology|July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology|May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Transplantation and Cellular Therapy|November 24, 2021
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and CriticismsMichele Malagola, Nicola Polverelli, Vicky Rubini, et al.
Transplantation Direct|February 27, 2023
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Nicola Polverelli, Massimo Martino, et al.
Pesticide Biochemistry and Physiology|April 25, 2026
Inhibitors of isocitrate lyase for weed suppression: Molecular modeling and biological evaluationPaulo Vinicius Moreira da Costa Menezes, Isabela Ferreira Henrique, Larissa Ayumi Kajihara, et al.
Bone Marrow Transplantation|October 31, 2017
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)L Giaccone, G Mancini, N Mordini, et al.
Pageof 53